Enhabit, Inc./$EHAB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Enhabit, Inc.
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services for adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing a life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.
Ticker
$EHAB
Sector
Primary listing
NYSE
Employees
10,700
Headquarters
Website
Enhabit, Inc. Metrics
BasicAdvanced
$434M
-
-$2.64
1.31
-
Price and volume
Market cap
$434M
Beta
1.31
52-week high
$10.91
52-week low
$6.47
Average daily volume
337K
Financial strength
Current ratio
1.57
Quick ratio
1.494
Long term debt to equity
85.349
Total debt to equity
91.405
Interest coverage (TTM)
1.41%
Profitability
EBITDA (TTM)
83.2
Gross margin (TTM)
48.88%
Net profit margin (TTM)
-12.83%
Operating margin (TTM)
5.31%
Effective tax rate (TTM)
-3.88%
Revenue per employee (TTM)
$100,000
Management effectiveness
Return on assets (TTM)
2.60%
Return on equity (TTM)
-20.37%
Valuation
Price to revenue (TTM)
0.417
Price to book
0.78
Price to tangible book (TTM)
-1.09
Price to free cash flow (TTM)
8.768
Free cash flow yield (TTM)
11.40%
Free cash flow per share (TTM)
0.976
Growth
Revenue change (TTM)
-0.39%
Earnings per share change (TTM)
1,400.15%
3-year revenue growth (CAGR)
-1.69%
3-year earnings per share growth (CAGR)
10.45%
What the Analysts think about Enhabit, Inc.
Majority rating from 8 analysts.
Bulls say / Bears say
Enhabit exceeded Q2 2025 expectations with net service revenue up 2.1% to $266.1 million and raised full-year guidance for revenue to $1.060–$1.073 billion and Adjusted EBITDA to $104–$108 million, reflecting an improved outlook.
The hospice segment posted its sixth straight quarter of growth, with average daily census increasing 12.3% year-over-year and Adjusted EBITDA up 53.8%, expanding margins in this higher-return business.
Ongoing deleveraging improved the balance sheet, with $10 million in bank debt repaid in Q2 and $45 million since Q1 2024, cutting interest expense by roughly $3.2 million and improving net debt/EBITDA to 4.3×.
Home health net service revenue fell 2.0% year-over-year to $205.9 million in Q2 2025, and Medicare patient visits and recertifications decreased, signaling continued weakness in the core business.
The home health segment’s net service revenue declined 5.9% year-over-year in Q1 2025, with visits per episode down 6.7% and average daily census decreasing 2.4%, highlighting ongoing pressure in the main revenue-generating segment.
UBS Group lowered its price target for Enhabit from $10.00 to $8.50 and maintained a “neutral” rating on August 8, 2025, showing analyst concerns about the sustainability of growth given segment challenges.
Data summarised monthly by Lightyear AI. Last updated on 9 Oct 2025.
Enhabit, Inc. News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Enhabit, Inc. stock?
Enhabit, Inc. (EHAB) has a market cap of $434M as of October 27, 2025.
What is the P/E ratio for Enhabit, Inc. stock?
The price to earnings (P/E) ratio for Enhabit, Inc. (EHAB) stock is 0 as of October 27, 2025.
Does Enhabit, Inc. stock pay dividends?
No, Enhabit, Inc. (EHAB) stock does not pay dividends to its shareholders as of October 27, 2025.
When is the next Enhabit, Inc. dividend payment date?
Enhabit, Inc. (EHAB) stock does not pay dividends to its shareholders.
What is the beta indicator for Enhabit, Inc.?
Enhabit, Inc. (EHAB) has a beta rating of 1.31. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.